title: The challenge of cross-trial comparisons using limited data.
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Jacob P
authors.initials: JP
authors.lastname: Laubach
authors.affiliation: Oncology / Hematology Care, Cincinnati, OH, USA.
authors.forename: Edward A
authors.initials: EA
authors.lastname: Faber
authors.affiliation: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
authors.forename: Peter
authors.initials: P
authors.lastname: Voorhees
authors.affiliation: Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
authors.forename: Javid
authors.initials: J
authors.lastname: Moslehi
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Cindy
authors.initials: C
authors.lastname: Varga
authors.affiliation: Millennium: The Takeda Oncology Company, Cambridge, MA, USA.
authors.forename: Liviu
authors.initials: L
authors.lastname: Niculescu
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Kenneth C
authors.initials: KC
authors.lastname: Anderson
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA, USA paul_richardson@dfci.harvard.edu.
authors.forename: Paul G
authors.initials: PG
authors.lastname: Richardson
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D009842:Oligopeptides / Q000008:administration & dosage* / Q000009:adverse effects*; D061988:Proteasome Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D009842:Oligopeptides; D061988:Proteasome Inhibitors
keywords: challenge; cross-trial; data
references.citation: Leukemia. 2013 Aug;27(8):1707-14
references.pmid: 23364621
references.citation: Blood. 2012 Oct 4;120(14):2817-25
references.pmid: 22833546
references.citation: Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):310-8
references.pmid: 23040437
references.citation: Blood. 2012 Aug 23;120(8):1589-96
references.pmid: 22791289
references.citation: Blood. 2012 Jun 14;119(24):5661-70
references.pmid: 22555973
references.citation: J Clin Oncol. 2012 Aug 20;30(24):2946-55
references.pmid: 22802322
references.citation: Haematologica. 2013 Nov;98(11):1753-61
references.pmid: 23935022
references.citation: Br J Haematol. 2012 Sep;158(6):739-48
references.pmid: 22845873
references.citation: Circ Res. 2013 Aug 30;113(6):754-64
references.pmid: 23989717
references.citation: N Engl J Med. 2005 Jun 16;352(24):2487-98
references.pmid: 15958804
references.citation: Lancet. 2010 Dec 18;376(9758):2075-85
references.pmid: 21146205
references.citation: N Engl J Med. 2008 Aug 28;359(9):906-17
references.pmid: 18753647